Inventor

SUH JOHN T

US57 patents

⚠️ This page may combine multiple inventors who share the name “SUH JOHN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SUH JOHN T

USV PHARMA CORP

Angiotensin-converting enzyme inhibitors

N-substituted-amido-amino acids

Antihypertensive amides

Antihypertensive amides

N-carboxy anhydride intermediates

Certain N-substituted-4-aryl-3,5-pyridine dicarboxylates and their antihypertensive use

Method of using phenyl-alkylene-2-pyridyl derivatives to increase cardiac contractility in a mammal

Antihypertensive spiro-cyclic compounds

Triazoloquinoxalin-4-ones

Pyrrolidines

Benzothiadiazole compounds for treating hypertension

Compounds having angiotensin converting enzyme inhibitory activity and diuretic activity

Compounds for treating hypertension

N-Substituted-amindo-amino acids

Antihypertensive N-substituted 1,4-dihydropyridines

1-(Substituted aminoalkyl)-1,4-dihydropyridines

Therapeutic dipeptides

N-(substituted piperazino)-1,4-dihydropyridine-3,5-carboxylic acid

N-Substituted-1-aminoalkyl-1,4-dihydropyridines

Substituted cyclic amines

Method of hypertensive treatment using phenyl-alkylene-2-pyridyl derivatives

Compounds for treating hypertension

Aroylaminoacid disulfides

Aroyl-aminoacids, amides and esters thereof

Amide analogs of calcitonin

Antihypertensive amides

Antihypertensive amides

Antihypertensive lactams

Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of use thereof

Cyclic amides

Compounds for treating hypertension

RORER PHARMACEUTICAL CORP

Bisarylamines

Aryl and heteroaryl substituted cycloalkyl compounds

Antihypertensive derivatives

Amide analogs of calcitonin

Treatment of conditions requiring enhanced oxygen availability to mammalian tissues

Treatment of conditions requiring enhanced oxygen availability to mammalian tissues

N-substituted-amido-amino acids

N-substituted-amido-amino acids

Angiotensin-converting enzyme inhibitors

Carboxyalkyl dipeptide compounds

Treatment of conditions requiring enhanced oxygen availability to mammalian tissues

RICHARDSON MERRELL INC

Method of treatment using 1-oxo-1h-2-benzopyran-3-carboxylic acid derivatives

N-substituted-dihydroxyphenethylamines

1,1-(Thiadialkylidene) ferrocene S-oxides

L-3-hydroxymethyltyrosine and salts thereof for lowering blood pressure

N-[4-(3,4-methylenedioxyphenyl)-but-2-yl]-β-(3,4-dihydroxyphenyl)ethylamine, and salts thereof

FREEMAN CHEMICAL CORP

Polyisocyanate prepolymers from scrap polyester and polyurethane foam products obtained therefrom

NICHOLAS INT LTD

Preparation of ethylamine derivatives

RHONE POULENC RORER PHARMA

Treatment of conditions requiring enhanced oxygen availability of mammalian tissues